Table 8.
Gene Set | Enrichment Score† | False-Discovery Rate q‡ |
---|---|---|
Enriched in glaucomatous RGCs | ||
Complement coagulation cascades | 0.45 | <0.0001 |
Fas pathway | 0.50 | <0.0001 |
Prostaglandin and leukotriene metabolism | 0.44 | <0.0001 |
JAK/STAT signaling | 0.42 | <0.0001 |
G protein coupled receptor database class A rhodopsin-like | 0.35 | <0.0001 |
Prostaglandin synthesis regulation | 0.47 | <0.0001 |
Caspase pathway | 0.47 | <0.0001 |
Depleted in Glaucomatous RGC | ||
Citrate cycle | 0.55 | <0.0001 |
Cholesterol biosynthesis | 0.81 | <0.0001 |
G-protein-coupled receptor pathway | 0.57 | <0.0001 |
A total of 639 canonical pathways gene sets (http://www.broad.mit.edu/gsea/msigdb/genesets.jsp?collection=CP#; provided in the public domain by the Broad Institute, Massachusetts of Technology, Cambridge, MA) were calculated by gene set enrichment analysis.
Enrichment score (ES) reflects the degree to which a gene set is overrepresented at the top or bottom of a ranked list of genes.
False-discovery rate is the estimated probability that a gene set with a given normalized ES represents a false-positive finding.